Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):e142-4. doi: 10.1097/QAI.0000000000000639.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • HIV Infections / complications*
  • Hepacivirus*
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / etiology*
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use
  • Portal Pressure / physiology*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a